Of the various oncogenes, we chose ERBB2 and PIK3CA as two likely candidates that may become important as routine tests in veterinary laboratories in the near future, as there is profound knowledge of the specific driver alterations in these genes in the cancers of dogs and cats, and targeted therapies are available for humans. This evidence concerns the gene PIK3CA and cancer.